The European Medicines Agency has identified a rare eye condition risk linked to Novo Nordisk’s semaglutide drugs.

Mr. Funk was the managing editor of Pleroma Media, and worked as a breaking news reporter at The Messenger after spending 25 ...

The European Medicines Agency’s safety committee said on Friday Novo Nordisk’s popular weight-loss and diabetes drugs Wegovy ...

Semaglutide, popularly known as Ozempic or Wegovy, has become a celeb-approved weight-loss drug. However, the effects are not ...

The European Medicines Agency's safety committee has concluded that the use of Novo Nordisk's popular weight-loss drug Wegovy ...

Ozempic, which was introduced into the UK in January 2019, having previously been approved in the US in 2017, is an ...

AS TikTok’s popularity shows no signs of waning, the app has quickly become a hub for promoting and sharing health content – including supposed quick fixes for shedding weight, crammed into ...

While semaglutide can aid weight loss for many who are prescribed ... is to combine the powers of the drug with improving 'behavioural patterns' around food. Indeed, by working to 'recognise genuine ...

So, what's the tea on microdosing? It's pretty much what it sounds like — taking smaller doses than the usual prescribed ...

Shares in pharmaceuticals group Novo Nordisk (NVO) remained in good shape today despite reports that its weight loss drugs ...

The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...

I've been a Novo Nordisk bull for quite some time now, and I wouldn't be as spooked by the situation. Here's why. Novo Nordisk got a two-year-plus head start in the white-hot obesity drugs market, ...